Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

CVTX

CV Therapeutics (CVTX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CVTX
DataOraFonteTitoloSimboloCompagnia
17/04/200923:01Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200922:32Edgar (US Regulatory)(25-NSE)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200922:15Business WireGilead Sciences Completes Acquisition of CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
17/04/200919:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
15/04/200921:54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
14/04/200912:06Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922:53Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200921:11Edgar (US Regulatory)Schedule 13GNASDAQ:CVTXCV Therapeutics (MM)
08/04/200916:49MarketwiredAnalystChoice.com Free Investment Opinion on PPDI, MEDX, CVTX and OSIPNASDAQ:CVTXCV Therapeutics (MM)
06/04/200922:12Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200922:05MarketwiredCV Therapeutics' Board of Directors Recommends Stockholders Accept Gilead Sciences' $20.00 per Share Cash Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
18/03/200921:44Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200921:42Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200918:53Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200918:52Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:CVTXCV Therapeutics (MM)
17/03/200914:07MarketwiredRun of 100% Profitable Stock Alerts Marches on for BullTradeNASDAQ:CVTXCV Therapeutics (MM)
16/03/200922:13Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)NASDAQ:CVTXCV Therapeutics (MM)
16/03/200921:57Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANASDAQ:CVTXCV Therapeutics Inc.
16/03/200921:01MarketwiredCV Therapeutics Announces Presentations at the American College of Cardiology 58th Annual Scientific SessionNASDAQ:CVTXCV Therapeutics (MM)
16/03/200920:01Dow Jones NewsUPDATE: US Drug Sector Rises After Bernanke CommentsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200919:49Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANASDAQ:CVTXCV Therapeutics Inc.
16/03/200916:10Dow Jones NewsDrug Sector Rises As Fed Chief Bernanke's Upbeat On RecessionNASDAQ:CVTXCV Therapeutics Inc.
16/03/200910:12Dow Jones NewsUPDATE:Astellas Pharma Abandons Offer To Buy CV TherapeuticsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200908:08Dow Jones NewsAstellas Pharma: Withdrawing Offer To Buy CV TherapeuticsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200907:42Business WireAstellas to Terminate Offer for CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
13/03/200913:45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNASDAQ:CVTXCV Therapeutics Inc.
12/03/200922:03Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:CVTXCV Therapeutics (MM)
12/03/200919:15PR Newswire (US)CV Therapeutics' Board of Directors Rejects Astellas' Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
12/03/200915:06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNASDAQ:CVTXCV Therapeutics Inc.
12/03/200914:22Dow Jones NewsGilead To Buy CV Therapeutics For $1.4 Billion In White-Knight BidNASDAQ:CVTXCV Therapeutics Inc.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CVTX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network